When combined using a fixed-effects model, we revealed a statistically significant positive relationship between plasma prolactin levels and risk of breast cancer, with the RR (95% CI) being 1.16 (1.04, 1.29) (P < 0.05). This evidence concerns the gene PRL and breast carcinoma.